Blog

What every patient should know: there are TWO, not one prostate cancer operations

By Alan Doherty, consultant urologist, BPC In almost everything I read about prostate cancer, the discussion is about the operation for cancer of the prostate, medically termed the radical prostatectomy. In other words, a single, all encompassing operation for prostate cancer. This is wholly different to the discussions I have with my patients. In these […]

Read more

Understanding and choosing between the different treatments for the enlarged prostate (BPH) 

By Alan Doherty Until quite recently, men seeking treatment for BPH (benign prostatic hyperplasia) had just two options: medication or the TURP procedure. This was a stark choice; medication is not always effective, particularly over time and can cause troublesome side-effects. The TURP (trans-urethral resection of the prostate) has serious potential complications, common side-effects and […]

Read more

Launch of our new results system to evaluate all surgery for the enlarged prostate

Birmingham Prostate Clinic has launched a new study to evaluate surgical treatments for the enlarged prostate (benign prostatic hyperplasia, BPH). We already have an established and nationally renowned results system for prostate cancer surgery and now the same principles are being applied to BPH surgery. “There are several different surgical options for the treatment of […]

Read more

BPC launches first private multi-disciplinary team (MDT) as benchmark for the highest standards

The Birmingham Prostate Clinic has launched the region’s first private Multi-Disciplinary (MDT) Team programme. The principle behind an MDT is for medical professionals of different disciplines to formally meet, discuss individual patients and their cancer treatment plan to consider the advantages and disadvantages of that plan. The MDT for the Birmingham Prostate Clinic includes consultant […]

Read more

DNA testing for cancer risk is now available and accessible at BPC

We are offering counselling and DNA testing for genes known to be associated with increased cancer risk. Although DNA testing for cancer risk is well established, until recently it cost thousands of pounds and it took months before results were known. Now a new assessment is available in the UK which makes genetics testing more […]

Read more

UroLift for BPH and other new horizons for treatment of benign prostatic enlargement

By Maya Harris, consultant urologist BPC Traditionally, only TURP with its significant side-effects was available for men who suffer from symptoms caused by benign prostatic hyperplasia (BPH).  GreenLight Laser prostatectomy, introduced by the Birmingham Prostate Clinic in 2007, was the first minimally-invasive option for BPH.  Recently, more procedures have appeared on horizon. I am a […]

Read more